Cancer is the second most common cause of death in the European Union. New approaches are urgently needed to address the growing number of cancer cases diagnosed each year.
In a bid to highlight the important yet highly delicate nature of Europe’s innovative industries, a new report, produced by the Deloitte Health Economics Group and commissioned by Janssen, has sought to evaluate the comparable risks incurred across five major industries.
